You are here

  • Home
  • Archive
  • Volume 33, Issue 4
  • Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer

Article metrics

Article menu
Download PDFPDF
Original research
Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer

 

Online download statistics by month:

Online download statistics by month: January 2023 to September 2024

AbstractFullPdf
Jan 20238653917
Feb 2023415214
Mar 2023381184
Apr 20237403629
May 20234692822
Jun 2023385148
Jul 2023355176
Aug 2023409168
Sep 2023345129
Oct 202329175
Nov 2023429134
Dec 202336877
Jan 2024478284
Feb 2024476177
Mar 20244952911
Apr 2024419126
May 2024234116
Jun 2024328206
Jul 2024485185
Aug 2024314135
Sep 202412452
Total8805381175